Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome
Thyoid Dysfucntion; Does it Affect the Short Term Outcome of Heptic Failure Patiens ?
1 other identifier
observational
100
1 country
1
Brief Summary
Liver plays an important role in the metabolism of thyroid hormones, as it is the most important organ in the peripheral conversion of tetraiodothyronine (T4) to triiodothyronine (T3) by Type 1 deiodinase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2023
CompletedFirst Posted
Study publicly available on registry
December 21, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedJanuary 16, 2024
January 1, 2024
3 months
December 12, 2023
January 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
short termoutcome
mortality during hospitalstay
(0 to 30 days)
Secondary Outcomes (1)
complications
(0 to 30 days)
Study Arms (2)
Hypothroid group
throid fuction will be evaluated on admission of hepatic failure patients, and the hypothroid patients will be enroled in this group.
Euthroid group
throid fuction will be evaluated on admission of hepatic failure patients, and the euothroid patients will be enroled in this group.
Interventions
throid fuction will be evaluated on admission of hepatic failure patients, and the hypothyroid patients will be enroled in this group.
throid fuction will be evaluated on admission of hepatic failure patients, and the euothyroid patients will be enroled in this group.
Eligibility Criteria
all hepatic failutre patients who will be admitted to ICU will be enrolled, and throid function will be assessed. Groupingwil be done based upon throid function
You may qualify if:
- \- hepatic fauiure patients
You may not qualify if:
- hypethyroid patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emad Zarief Kamel Said
Asyut, 71111, Egypt
Related Publications (2)
Punekar P, Sharma AK, Jain A. A Study of Thyroid Dysfunction in Cirrhosis of Liver and Correlation with Severity of Liver Disease. Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):645-650. doi: 10.4103/ijem.IJEM_25_18.
PMID: 30294575BACKGROUNDMcCormick PA. Sherlock's Diseases of the Liver and Biliary System Textbook. Hepatic Cirrhosis. In: Dooley JS, Lok AS, Burroughs AK, Heathcote EJ, editors. 12th ed. Ch. 7. UK: Wiley-Blackwell, A John Wiley and Sons, Ltd; 2011. pp. 103-8.
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
December 12, 2023
First Posted
December 21, 2023
Study Start
January 1, 2024
Primary Completion
April 1, 2024
Study Completion
May 1, 2024
Last Updated
January 16, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share